Sudden blindness due to bilateral central retinal artery occlusion in a patient on eltrombopag.
Blood-Med Clinic, 1108 Crawford House, 70 Queen's Road Central, Hong Kong, China, auwing@hotmail.com.
Wing-Yan
WY
Au
Edmond S K
ES
Ma
Pak Chin
PC
Chow
Yiu-Ting
YT
Kan
D001565:Benzoates / Q000008:administration & dosage / Q000009:adverse effects*; D001766:Blindness / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000009:adverse effects*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy / Q000473:pathology; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects*; D053628:Receptors, Thrombopoietin / Q000819:agonists; D020127:Recovery of Function; D015356:Retinal Artery Occlusion / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D001565:Benzoates; D005343:Fibrinolytic Agents; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; C520809:eltrombopag; D008775:Methylprednisolone